Cancer Antigen 27-29 (CA 27-29)
CA 27-29 is read like a river gauge after a storm. A single waterline tells you almost nothing; whether the line is climbing or receding is the whole message.
Part of the Tumor Markers — see all 11 values together, including Alpha-Fetoprotein, Beta-hCG, Cancer Antigen 125.
One CA 27-29 value barely speaks. The direction across repeated draws is the entire message, and almost everything that makes this test useful lives in the gap between those two facts. CA 27-29 is a tumor marker for breast cancer: the substance measured is a protein made by the MUC1 gene, detected in a blood sample. The number that prints next to it on a report invites a simple reading, below the cutoff is good, at or above it is bad, and that reading is the one mistake this page exists to take apart.
A better way to picture it is a river gauge read after a storm. The single waterline on the post matters far less than whether the line is climbing or receding week to week. A gauge reading of "34" tells a hydrologist almost nothing in isolation; what they want is yesterday's mark and the day before's, so they can see which way the water is moving. CA 27-29 works the same way. The National Cancer Institute frames it as a monitoring tool, used to assess whether treatment is working or whether cancer has recurred or spread, and explicitly not as a screening test.
That single distinction reorganizes how you should read your own result. The question is not "is my number high?" It is "which way is my line moving across repeated tests?"
How to read a CA 27-29 result
U/mLThe NCI is explicit that a single tumor marker level does not mean cancer is present or absent. One draw is a dot; the test needs at least two to draw a line.
A typical lab cutoff sits around 38 U/mL, though this varies by assay and isn't a fixed authority-blessed threshold. A normal value doesn't rule out recurrence, since not every cancer raises the marker.
Benign conditions can raise it, and the number above the line on one draw is a prompt to retest and compare against imaging, not a diagnosis.
With serial testing, a falling level usually means treatment is working, per MedlinePlus. The slope, not the snapshot, is what carries the signal.
A line climbing over consecutive draws can flag possible recurrence, which is exactly the pattern oncologists track. It's read alongside scans and a clinical exam, never on its own.
Notice that the rows that actually carry meaning are the bottom two, the ones about direction. The cutoff number near 38 U/mL shows up across consumer pages, but no NIH-family source publishes it as a canonical line in the sand, and the value shifts between assays. Treating it as a verdict is the river-gauge error: reading the waterline and ignoring the current.
Why a single value says so little
CA 27-29 detects a fragment of the MUC1 antigen, a protein that many ordinary tissues produce, well beyond tumor cells. That biology is the root of two facts the NCI states plainly, and both cut against the one-number reading.
Why the single number is unreliable
-
Benign conditions can raise it
The NCI notes noncancerous conditions can sometimes push a tumor marker level up. An elevated CA 27-29 in someone with clear scans is a known pattern, the kind of false positive that makes a single draw untrustworthy rather than a contradiction.
-
Cancer can be present with a normal level
Not everyone with a given cancer has a raised marker. A reassuring number doesn't rule recurrence out, which is why imaging and exam stay in the picture.
-
It's not sensitive enough to screen
The NCI says circulating markers don't work well for screening, because they miss real disease and flag people without it. That's why CA 27-29 is reserved for following a cancer already diagnosed.
Put together, these are why the test is run as a series rather than a one-off. The NCI describes periodic, or serial, measurements made during and after treatment as the thing that actually indicates whether a tumor is responding or returning. MedlinePlus puts the everyday version of it simply: with serial testing, a falling level usually means treatment is helping, and the tests are built to find cancer that remains or comes back after treatment, with only a limited role in screening.
What a rising or falling line means
This is where the gauge metaphor does real work. A reading of 34 that followed a 25 a few months earlier tells a different story than a 34 that followed a 48, even though both share the same waterline today. The first line is climbing; the second is receding. Doctors read the slope.
That's also why the everyday worries people bring to this number are best answered by direction. "My CA 27-29 is going up but it's still normal" is a question about slope inside the range. "It's above 38 but my scans are clear" is a question about a single dot that hasn't been confirmed by a second one. In both cases the move is the same: repeat the test, keep the method constant, and let the trend speak.
There's an important limit on how confidently anyone reads that trend. The American Society of Clinical Oncology, as reported through Breastcancer.org's coverage of its guidance, does not recommend CA 15-3 or CA 27-29 for screening or routine surveillance, and holds that there isn't enough evidence to use the level alone to decide whether a cancer is responding to treatment. The marker is used alongside clinical evaluation, gathered over serial draws, never as a standalone verdict. The slope is the signal, but it's one input among several.
Reading your CA 27-29 over time
-
1
Talk to your oncologist before reading anything into it
CA 27-29 belongs to a treatment-monitoring conversation, not a self-check. Bring the number to the person managing your care and let them place it.
-
2
Keep the lab and method constant
Different assays can report different values for the same blood. Using the same lab each time means a change reflects you, not the measurement.
-
3
Compare against your own prior results
A value is a dot; two or more make a line. The NCI describes serial measurements during and after treatment as what reveals response or return.
-
4
Read it next to scans and exam, never alone
ASCO guidance holds the level isn't enough by itself. Imaging, physical exam, and symptoms stay part of the picture, normal number or not.
-
5
Treat one out-of-range result as a prompt, not a diagnosis
Benign conditions can raise it and a single value isn't conclusive, so the usual next step is a repeat draw read in context.
Where CA 27-29 sits among the markers
CA 27-29 doesn't work alone, and it isn't the only marker in its family. It detects a different fragment of the same MUC1 antigen that CA 15-3 measures, which is why the two are often discussed together for breast cancer monitoring. CEA is sometimes followed alongside it in the same setting. The broader tumor markers panel gathers these with markers aimed at other cancers, such as CA 125 for ovarian patterns, CA 19-9 for pancreatic and biliary ones, and AFP for liver and germ-cell contexts. None of them is a screening test, and all of them share the same reading discipline.
That reading discipline is what this page comes down to. A tumor marker is a line on a chart, not a dot on a report, and the value of CA 27-29 lives in how it moves between draws. Trend direction often says more than any single value, and for this marker the trend is more than just the better reading of the two. It is essentially the only thing the snapshot was ever standing in for.
Sources
- Tumor Markers in Common Use — National Cancer Institute
- Tumor Markers Fact Sheet — National Cancer Institute
- Tumor Marker Tests — MedlinePlus, National Library of Medicine
- Guidelines Issued on Biomarkers for Metastatic Breast Cancer — Breastcancer.org
Written and reviewed by BloodSight Editorial Team · Last updated
See your Cancer Antigen 27-29 on one timeline.
BloodSight calibrates the reference range to your sex, age, and lab — and shows every value across every visit.
In your personal range
Normal ranges
| Group | Range | Unit |
|---|---|---|
| Adult Male | 0–38 | U/mL |
| Adult Female | 0–38 | U/mL |
Reference ranges may vary by laboratory and individual factors.
Cancer Antigen 27-29 — Common Questions
Why can't CA 27-29 be used to screen me for breast cancer?
My CA 27-29 is above 38 but my scans are clear. What does that mean?
My number went from 25 to 34 but is still in range. Does a rise inside normal matter?
Can breast cancer come back even if CA 27-29 stays normal?
What non-cancer conditions can push CA 27-29 up?
Why does my oncologist insist on using the same lab every time?
Disclaimer
This content is for informational and educational purposes only. It is not intended as medical advice, diagnosis, or treatment recommendation. Reference ranges may vary by laboratory. Always discuss your results with a qualified healthcare professional.
Related Tests
One CA 15-3 reading rarely settles anything. Built for serial monitoring, the test speaks through its trajectory, not its latest figure.
Carcinoembryonic antigen is a watch-post, not a search party. Its real job starts after a cancer is found: tracking whether the number creeps back up between scans.
The blood test named for cancer trips for menstruation, pregnancy and fibroids. Here is what a number over 35 actually tells you, and the screening question it can't answer.
CA 19-9 is the main blood marker doctors track in pancreatic and bile-duct cancers. Its strangest quirk: a sizable minority of people are simply built not to produce it at all.
AFP is read as a cancer marker, but a liver healing from hepatitis or cirrhosis raises it too. Here is how to read the number without panic.